Evidence map›Paper›PMID 40565152›Full record

ArticleInternational journal of molecular sciences2025

Evaluating the Antitumor Potential of Cannabichromene, Cannabigerol, and Related Compounds from

Andrés David Turizo Smith, Nicolás Montoya Moreno, Josefa Antonia Rodríguez-García, Juan Camilo Marín-Loaiza, Gonzalo Arboleda Bustos

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andrés David Turizo SmithDepartamento de Patología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá 111221, Colombia.ORCID 0000-0003-0358-4008
Nicolás Montoya MorenoDepartamento de Química, Facultad de Ciencias, Universidad Nacional de Colombia, Bogotá 111221, Colombia.
Josefa Antonia Rodríguez-GarcíaGrupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología, Bogotá 111221, Colombia.ORCID 0000-0002-8705-7178
Juan Camilo Marín-LoaizaDepartamento de Farmacia, Facultad de Ciencias, Universidad Nacional de Colombia, Bogotá 111221, Colombia.
Gonzalo Arboleda BustosDepartamento de Patología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá 111221, Colombia.

Funding

ATENEA (agencia distrital para la educación superior, la ciencia y al tecnologia) contract #396-2023
6 · The paper itself

Abstract

Malignant gliomas, including glioblastoma multiforme (GBM), are highly aggressive brain tumors with a poor prognosis and limited treatment options. This study investigates the antitumor potential of bioactive compounds derived from

Indexed as

Antineoplastic Agents, PhytogenicBrain NeoplasmsCannabinoidsCannabisGliomaPiper nigrumCannabidiolCell Line, TumorCell SurvivalGene Expression Regulation, NeoplasticHumansMolecular Docking SimulationProtein KinasesReceptors, CannabinoidAntineoplastic Agents, PhytogenicCannabidiolcannabigerolCannabinoidsGPR55 protein, humanProtein KinasesReceptors, Cannabinoidcannabichromenecannabidiolcannabidiolic acid (CBDA)cannabigerolCannabis sativaCCF-STTG1glioblastomaGPR55PINK1piperinePiper nigrumT98GU87MG

Identifiers

PMID40565152
PMCPMC12192948

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.